share_log

BTIG Maintains Buy on GeneDx Hldgs, Raises Price Target to $19

Benzinga ·  Apr 30 07:43

BTIG analyst Mark Massaro maintains GeneDx Hldgs (NASDAQ:WGS) with a Buy and raises the price target from $15 to $19.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment